Pages that link to "Q93603855"
Jump to navigation
Jump to search
The following pages link to A SPECIAL MEETING REVIEW EDITION: Updates in the Treatment of Hepatitis C Virus Infection From EASL 2012: The 47th Annual Meeting of the European Association for the Study of the LiverApril 18-22, 2012 • Barcelona, SpainSpecial Reporting on:• Safety (Q93603855):
Displaying 20 items.
- Oral antiviral therapies for chronic hepatitis C infection (Q26830426) (← links)
- Drug-drug interactions during antiviral therapy for chronic hepatitis C (Q26864887) (← links)
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study (Q33956796) (← links)
- Prediction of treatment week eight response & sustained virologic response in patients treated with boceprevir plus peginterferon alfa and ribavirin (Q33988984) (← links)
- Current and future therapies for hepatitis C virus infection (Q34036762) (← links)
- Direct-acting antiviral agents for hepatitis C virus infection (Q34321440) (← links)
- Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat? (Q34485549) (← links)
- The changing burden of hepatitis C virus infection in the United States: model-based predictions. (Q35168083) (← links)
- Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States (Q35619161) (← links)
- HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms (Q36379622) (← links)
- Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy (Q37042436) (← links)
- Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States (Q37286544) (← links)
- Direct-acting antiviral agents in patients with hepatitis C cirrhosis (Q37663921) (← links)
- Interferon-free hepatitis C therapy: how close are we? (Q38039192) (← links)
- Boceprevir and personalized medicine in hepatitis C virus infection (Q38066185) (← links)
- Boceprevir: a review of its use in the management of chronic hepatitis C genotype 1 infection (Q38066535) (← links)
- Novel therapies for hepatitis C - one pill fits all? (Q38117549) (← links)
- Treatment decisions and contemporary versus pending treatments for hepatitis C. (Q38135774) (← links)
- HCV enters the twenty-first century (Q42281701) (← links)
- A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2013: The 48th Annual Meeting of the European Association for the Study of the LiverApril 24-28, 2013 • Amsterdam, The NetherlandsSpecial Reporting (Q93587612) (← links)